Hosted on MSN
Solventum (NYSE:SOLV) exceeds Q1 CY2026 expectations
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q1 CY2026 results , but sales fell by 3% year on year to $2.01 billion. Its non-GAAP profit of $1.48 per share was 9.3% above analysts’ ...
SOLV | Complete Solventum Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results